SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs quarterly results beat expectations and marked its first profitable quarter as a public company, with rapid growth in AI compute driving bullish reactions and analyst upgrades. Traders are also debating whether heavy spending and an upcoming share unlock could weigh on the stock, while a possible Tesla merger remains exploratory speculation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs earnings update drew attention as a softer revenue outlook and reduced advertising forecast overshadowed a profit beat, prompting a sharp selloff. Traders are split between concerns about slowing growth, ad execution and competition, and views that the reaction is excessive given the companys continued profitability.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary quarterly outlook sharply exceeded expectations, citing strong AI-server demand and improved gross margins, sparking a rally and bullish talk of a re-rating and short covering. Traders remain divided over whether margins, cash flow, and execution can sustain the improvement, with some wary that the initial pop could fade.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention after a sharp, high-volume rebound, with traders focused on the anticipated 80th-event trigger and final survival analysis in its Phase 3 REGAL trial of GPS for AML. Buyout, leak, and short-squeeze theories are circulating, while others stress that no result or deal is confirmed and the trial outcome remains uncertain.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs planned spectrum acquisition and Starlink Mobile ambitions have raised concerns about future competition for AT&T and other major carriers, weighing on telecom shares. Traders are split between viewing the threat as a long-term risk and calling the selloff an overreaction, with many buying the dip and pointing to AT&Ts existing fiber and wireless network.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MS conference data, especially preliminary azer-cel Phase 1 findings in progressive MS that traders describe as showing disability improvements and encouraging safety in a small cohort. The reaction is optimistic but tempered by the early, limited evidence, with investors also watching long-term BRIUMVI outcomes and switching data.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias Q3 results are the main focus, with traders looking for evidence that AI and cloud orders and AI-RAN partnerships can translate into recognized revenue and profit. Bulls see the Nvidia, T-Mobile and SoftBank developments as grounds for a rerating, while skeptics question execution and note the stocks weak price response to positive news.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is drawing attention for persistent share-price underperformance despite growth in its commercial business, with many traders blaming weak confidence in management and the companys acquisition-focused strategy. The debate centers on debt and dilution concerns versus the potential of upcoming Navenibart and Netherton data to support the pipeline and restore confidence.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgicals quarterly results beat expectations, but traders focused on the narrowed procedure-growth outlook, planned pricing reductions that could pressure revenue per procedure, and an antitrust settlement charge. Some see the selloff as an overreaction to a one-time cost given continued business growth, while others are concerned about slowing growth and margin pressure.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins rebound has traders watching whether it can clear nearby resistance, with many anticipating a breakout and short squeeze while skeptics warn the move may be a bull trap or give way to another pullback. Discussion also references institutional optimism and ETF buying, but the main focus is whether the price momentum can hold.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers

Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 28.3% to $21.53 during Friday's pre-market session. The company's market cap stands at $27.4 million.
Akanda (NASDAQ:AKAN) shares increased byread more...

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday's regular session. The company's market cap stands at $11.5 million.
Lakewood-Amedex (NASDAQ:LABT) shares movedread more...

Advanced Biomed Stock Is Surging: Here's Why It Is Trending

Advanced Biomed stock surges after withdrawing its SEC Form S-1, removing a planned securities offering and potential shareholder dilution.read more...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million.
Advanced Biomed (NASDAQ:ADVB) stock movedread more...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.1 million.
Advanced Biomed (NASDAQ:ADVB) sharesread more...

Institutional Giants Are Piling into Four of These NASDAQ Plays

The market is currently seeing a flurry of activity as companies across the biotech and technology sectors secure substantial funding and execute strategic transformations. $CNSP, $KBLB, $PN, $RLYB, $ADVB, $CLNN, $CABA

Why Advanced Biomed Shares Are Cooling Off Wednesday?

Shares of Advanced Biomed are trading lower Wednesday. Learn why the stock is pulling back after the Acellent Technologies deal.read more...

Biotech Stocks To Watch Now - April 7th

Danaher, argenex, United Therapeutics, Vertex Pharmaceuticals, and Advanced Biomed are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares...

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

Advanced Biomed Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.80
Prev Close	$4.16
Open	$4.25
Dividend Yield	0.00%
50-Day Moving Average	$7.36
Beta	-0.03
Avg. Volume	64,723.76
PE Ratio	-47.50

52-Week High	$24.23
52-Week Low	$3.61
Market Capitalization	$6.28M
EPS (Annual)	-$0.1888
Price to Book	16.29
Revenue Per Employee	$342.75

Feed

News

Sentiment

Fundamentals

Info

ADVB Fundamentals